Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00054275
Status:
COMPLETED
Last Update Posted:
2016-02-17
First Post:
2003-02-05
Brief Title:
Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer
Sponsor:
Paula Silverman MD
Organization:
Case Comprehensive Cancer Center
Organization Data
Organization:
Case Comprehensive Cancer Center
Class:
OTHER
Study ID:
CWRU1102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Paula Silverman MD
Lead Sponsor Class:
OTHER
Responsible Party:
Paula Silverman MD
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Case Comprehensive Cancer Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |